| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
OKDBV Stock Overview
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally.
Rewards
Risk Analysis
No risks detected for OKDBV from our risk checks.
Oriola Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.99 |
| 52 Week High | €2.31 |
| 52 Week Low | €1.72 |
| Beta | 0.71 |
| 1 Month Change | -2.65% |
| 3 Month Change | -1.44% |
| 1 Year Change | 2.16% |
| 3 Year Change | -3.12% |
| 5 Year Change | -43.74% |
| Change since IPO | 1.85% |
Recent News & Updates
Shareholder Returns
| OKDBV | FI Healthcare | FI Market | |
|---|---|---|---|
| 7D | -1.9% | -0.1% | 2.0% |
| 1Y | 2.2% | -31.7% | -18.6% |
Return vs Industry: OKDBV exceeded the Finnish Healthcare industry which returned -31.7% over the past year.
Return vs Market: OKDBV exceeded the Finnish Market which returned -18.6% over the past year.
Price Volatility
| OKDBV volatility | |
|---|---|
| OKDBV Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in FI Market | 8.8% |
| 10% least volatile stocks in FI Market | 3.3% |
Stable Share Price: OKDBV is less volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: OKDBV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 892 | Elisa Markula | https://www.oriola.com |
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops.
Oriola Oyj Fundamentals Summary
| OKDBV fundamental statistics | |
|---|---|
| Market Cap | €360.76m |
| Earnings (TTM) | €18.20m |
| Revenue (TTM) | €1.94b |
19.8x
P/E Ratio0.2x
P/S RatioIs OKDBV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OKDBV income statement (TTM) | |
|---|---|
| Revenue | €1.94b |
| Cost of Revenue | €1.55b |
| Gross Profit | €388.90m |
| Other Expenses | €370.70m |
| Earnings | €18.20m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 27, 2022
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 20.01% |
| Net Profit Margin | 0.94% |
| Debt/Equity Ratio | 61.9% |
How did OKDBV perform over the long term?
See historical performance and comparison